{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:23:10Z","timestamp":1788009790649,"version":"build-2784847793"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,5,28]],"date-time":"2011-05-28T00:00:00Z","timestamp":1306540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10067-011-1782-6","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T02:01:08Z","timestamp":1306461668000},"page":"1369-1372","source":"Crossref","is-referenced-by-count":34,"title":["The efficacy and safety of etanercept in patients with rheumatoid arthritis and spondyloarthropathy on hemodialysis"],"prefix":"10.1007","volume":"30","author":[{"given":"Soner","family":"Senel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus","family":"Ugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timucin","family":"Kasifoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Tunc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli","family":"Cobankara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,28]]},"reference":[{"key":"1782_CR1","first-page":"104","volume-title":"Autoimmune rheumatic disease","author":"J Morrow","year":"1999","unstructured":"Morrow J, Nelson L, Watts R, Isenberg D (1999) Autoimmune rheumatic disease, 2nd edn. Oxford University Press, Oxford, pp 104\u2013146","edition":"2"},{"key":"1782_CR2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun J, Bollow M, Remlinger G et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58\u201367","journal-title":"Arthritis Rheum"},{"key":"1782_CR3","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/17.11.2003","volume":"17","author":"S Tuglular","year":"2002","unstructured":"Tuglular S, Yalcinkaya F, Paydas S et al (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17:2003\u20132005","journal-title":"Nephrol Dial Transplant"},{"key":"1782_CR4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.rhu.0000135555.83088.a2","volume":"10","author":"A Swarup","year":"2004","unstructured":"Swarup A, Sachdeva N, Schumacher HR Jr (2004) Dosing of antirheumatic drugs in renal disease and dialysis. J Clin Rheumatol 10:190\u2013204","journal-title":"J Clin Rheumatol"},{"key":"1782_CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/acb.2006.028","volume":"61","author":"O Boey","year":"2006","unstructured":"Boey O, Van Hooland S, Woestenburg A, Van der Niepen P, Verbeelen D (2006) Methotrexate should not be used for patients with end-stage kidney disease. Acta Clin Belg 61:166\u2013169","journal-title":"Acta Clin Belg"},{"key":"1782_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rheumatology\/kei264","volume":"45","author":"M Hammoudeh","year":"2006","unstructured":"Hammoudeh M (2006) Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Rheumatology 45:357\u2013359","journal-title":"Rheumatology"},{"key":"1782_CR7","author":"S Kobak","year":"2010","unstructured":"Kobak S (2010) Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis. Rheumatol Int. doi: 10.1007\/s00296-010-1457-7","journal-title":"Rheumatol Int"},{"key":"1782_CR8","first-page":"440","volume":"28","author":"E Marocchi","year":"2010","unstructured":"Marocchi E, Spadaro A, Giannakakis K, Priori R, Valesini G (2010) Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis. Clin Exp Rheumatol 28:440","journal-title":"Clin Exp Rheumatol"},{"key":"1782_CR9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1211\/jpp.57.11.0005","volume":"57","author":"BR Don","year":"2005","unstructured":"Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA (2005) The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol 57:1407\u20131413","journal-title":"J Pharm Pharmacol"},{"key":"1782_CR10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5414\/CNP73431","volume":"73","author":"BR Don","year":"2010","unstructured":"Don BR, Kim K, Li J, Dwyer T, Alexander F, Kaysen GA (2010) The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients. Clin Nephrol 73:431\u2013438","journal-title":"Clin Nephrol"},{"key":"1782_CR11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjmed.2005.01.028","volume":"118","author":"A Fern\u00e1ndez-Nebro","year":"2005","unstructured":"Fern\u00e1ndez-Nebro A, Tomero E, Ortiz-Santamar\u00eda V et al (2005) Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med 118:552\u2013556","journal-title":"Am J Med"},{"key":"1782_CR12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1365-4632.2008.03619.x","volume":"47","author":"N Cassano","year":"2008","unstructured":"Cassano N, Vena GA (2008) Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection. Int J Dermatol 47:980\u2013981","journal-title":"Int J Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1782-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1782-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:50Z","timestamp":1559119910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1782-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,28]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1782"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1782-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,28]]}}}